M ultiple sclerosis (MS) is a chronic inflammatory demyelinating condition of the human CNS characterized by recurrent episodes of immune-mediated demyelination and axonal loss (1) . Among recently proposed therapeutic strategies, transplantation of myelin-forming precursor cells or stem cells (SC) has generated both interest and reservations (2) (3) (4) . Bone marrow-derived mesenchymal stem cells (BMSC) provide the structural and functional support for the generation of blood cell lineages from hematopoietic SCs (5) . BMSCs expanded in vitro can generate progeny that differentiate into multiple cell lineages (6) . Several recent reports have demonstrated that under specific experimental conditions, BMSCs can differentiate into bone cells (7) , fat cells (8) , hepatocytes (9) , glia, and neurons (10, 11) . The neuron-differentiation potential of BMSCs has attracted intense interest in the possible application of BMSCs in cell and gene therapy strategies for neurologic diseases (12) . BMSCs have also been shown to modulate immune responses by influencing some T cell, B lymphocyte, NK, and dendritic cell functions (13) (14) (15) . The mechanisms underlying these effects are largely unknown but are likely to be mediated either by direct cell-cell contact and/or soluble factors such as TGF-b1 (16) , hepatocyte growth factor (17) , NO (18) , and PGE 2 (19) (20) (21) .
MicroRNAs (miRs) have become recognized as important gene regulators in eukaryotic organisms, including SCs (22) . miRs are a class of nonprotein-coding small RNAs that have a specific secondary stem-loop hairpin structure within their primary transcripts with a higher minimal folding free energy index (23) . miRs negatively regulate gene expression at the posttranscriptional level through direct mRNA cleavage (24) , translational repression (25) , or mRNA decay mediated by miR deadenylation (26) . Although many endogenous miRs have been identified in mammals, specific functions have remained largely undefined. However, recent studies indicate that the expression profiles of miRs in SCs are different from other tissues (27) . This suggests that miRs may play an essential role in SC self-renewal, differentiation, and other functions (28) . With respect to immunoregulation, miRs have been shown to be involved in the regulation of several immune responses in both innate and acquired immunity.
In this study, we analyzed the expression profile of miRs in BMSCs as a correlate of their immunoregulatory potential. We found that several miRs were significantly upregulated, including miR-146a, in neuronally differentiated BMSCs that had lost immunoregulatory activity in mice with experimental autoimmune encephalomyelitis (EAE), an animal model for MS. We found that miR-146a targeted PGE 2 -synthase 2, which resulted in decreased secretion of PGE 2 . Because PGE 2 was shown to contribute to the immunosuppressive activity of BMSCs (19) (20) (21) , we analyzed whether the functional relation between miR-146a and BMSC-induced immunosuppression depended on PGE 2 .
Materials and Methods

Isolation of BMSCs
Normal SJL mice, 6-8 wk old, were used for the isolation of BMSC. Bone marrow cells were obtained from the femurs and tibias of euthanized mice by flushing with PBS. Cells were washed twice in sorting medium that consisted of PBS supplemented with 0.5% BSA (Sigma-Aldrich, St. Louis, MO), and subjected to negative magnetic sorting using the Lineage Cell Depletion Kit (Miltenyi Biotec, Bergisch Gladbach, Germany). Depletion of cells expressing lineage Ags by mAbs and magnetic beads resulted in a pure fraction of Lin 2 cells. Purity of the Lin 2 fraction was invariably .98%, as assessed by flow cytometry using Lineage Cocktail (anti-CD3e, anti-CD11b, anti-CD45R/B220, anti-Ly6G and Ly-6C, and anti-TER-119; BD Biosciences, San Jose, CA) (29) . Cells retained differentiation capacity and were characterized by lack of CD34, CD11b, and CD45. Isolation of murine bone marrow Lin 2 Sca-1 + cells (Lin 2 Sca-1 + BMSCs) was performed using MACS Sca-1 MultiSort Kit (Miltenyi Biotec., Bergisch Gladbach, Germany). After enrichment, Sca-1 expression was up to 20%, compared with ,1% in Lin 2 BMSCs, and in this population, c-kit was ,2%. Sca-1 defines pluripotent capacity of SC population (30, 31) . In addition, examining these cells gene expression profile with Affymetrix GeneChip, we found numerous mesenchymal SC (MSC)-specific markers, such as cd44, alcam, casp3, eng, itgav, pdgfrb, prom1, vcam1, and thy1. Moreover, several other genes associated with MSCs were also identified: anxa5, bglap, ctnnb1, gtf3a, hgf, icam1, itgb1, nudt6, pigs, ptprc, tnf, vegfa, vim, and vwf. These data indicate that isolated lineage-negative murine bone marrow cell population enriched with Sca-1 possesses differentiation potential and meets criteria for MSCs (32) . . The differentiation of neural SCs was induced by removing the bFGF-containing medium and resuspending cells in fresh bFGF-free medium. Examining these cells gene expression profile with Affymetrix GeneChip, we found expression of neural SC markers (abcg2, bmi-1, cxcr4, notch-1, slain1, and vimentin), neural lineage markers (alcam, thy 1, l1cam, latexin, vamp-1, tle3, and pax6), and glial lineage markers (cd44, claudin-11, fgfr4, fgfr1, gmf-b, mbp, meteorin, and ngfr).
Neural differentiation of SCs
As a control, BMSCs cultured in nondifferentiated medium supplemented with bFGF (cBMSC) were used. All experiments were performed after 4 and 7 d of differentiation.
Induction and treatment of EAE
Female SJL mice, 6-8 wk old, were obtained from the Animal Care Department, Medical University of Lodz. All animals were housed in pathogen-free conditions and were treated according to the guidelines of the local Animal Ethics Committee. Mice were immunized s.c. according to a previously published protocol using 0.15 mg PLP 139-151 in IFA (Difco Laboratories), supplemented with 4 mg/ml Mycobacterium tuberculosis. Immunization with PLP peptide was followed by i.v. administration of 400 ng pertussis toxin (Sigma-Aldrich), on days 0 and 2.
Freshly isolated Lin 2 Sca-1 + BMSCs (fBMSCs), neural-differentiated Lin 
Proliferation assay
ELISA
Quantitative analysis of PGE 2 was performed by ELISA, using commercially available kits (R&D Systems). Supernatants were derived from BMSC cultures during differentiation and in nondifferentiated medium (on 4 and 7 d) or in 24-h culture of fBMSCs. Supernatants were frozen and analyzed according to the manufacturer's instructions. Standard, control, and test samples were added to each well and incubated for appropriate time with adequate primary Ab and conjugate. After washing, substrate solution was added to each well for 30 min at room temperature in the dark. Finally, Stop Solution was added and the OD of each well was determined within 30 min using a microplate reader (wavelength 450 nm).
Western blotting
Cell lysates were obtained from cultures of fBMSCs (24 h), nBMSCs, and cBMSCs. Cells were pelleted and lysed in lysing buffer (20 mM Tris-HCl [pH 7.4], 0.15 M NaCl, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM Na 3 VO 4 , 1 mM PMSF, 1 mg/ml aprotinin and leupeptin). Lysates were centrifuged at 14,000 rpm for 5 min. An equal amount of protein from each cell lysate was separated by SDS-PAGE electrophoresis and transferred to PVDF membranes (Immobilon, Millipore, MA). Membranes were blocked with 5% dried milk in TBS-TBS (Sigma Aldrich) overnight, followed by incubation for 1-2 h with PGE 2 synthase-1, PGE 2 synthase-2, and PGE 2 synthase (cytosolic) (rabbit 1:500; Cayman Chemical, Ann Arbor, MI), and GAPDH (Abcam, Cambridge, U.K.). After washing with TBS, blots were incubated with peroxidase-coupled secondary anti-rabbit Ab (1:20,000; Sigma-Aldrich). Proteins were detected by ECL-ECL (Amersham Biosciences). Densitometry was performed for comparison of Western blot data (Alpha Innotech, San Leandro, CA).
miR analysis
Total RNA samples were isolated from fBMSCs and nBMSCs by using the miRVana RNA Isolation kit (Ambion, Austin, TX) according to the manufacturer's protocol. Reverse transcription was performed with miR146a-specific primer, mmu miR-146a (TaqMan MicroRNA Assays; Applied Biosystem, Foster City, CA). Real-time PCR with TaqMan probes was normalized by small nucleolar RNA levels. To make cDNA for each TaqMan miR assay, we incubated 10 ng total RNA with 0.15 ml dNTPs (100 nM), 1.5 ml 103 reaction buffer, 0.19 ml RNase inhibitor, 1 ml reverse transcriptase, and 3 ml gene-specific primer in a 15-ml reaction. Realtime PCR was performed using an Applied Biosystems 7500 Sequence Detection System. Quantification of relative expression levels was performed using standard curves for target genes and the endogenous control. The value of each control sample was set at 1 and was used to calculate the fold change in target genes.
For miRCURY LNA Array miR, RNA samples were concentrated to at least 1 mg/ml. The Exiqon miRCURY LNA array version 10.0 (http://www. exiqon.com) (33) was used for data analysis in this study. All array data have been deposited in the Gene Expression Omnibus database (http:// www.ncbi.nlm.nih.gov/geo) under accession number GSE43621.
Anti-miR treatments
A 22-oligonucleotide, anti-miR-146a (antagomir; 59-AACCCAUGGAA-UUCAGUUCUCA-39) was used at 10-nM concentration complexed with the transfection reagent Lipofectamine 2000 (2 ml/cell; Invitrogen, Carlsbad, CA). Anti-miR-146a (or Lipofectamine control) was used in nBMSCs cultured in 24/wells (0.5 3 10 6 cells/well). After 4 d of culture, cells were used for the transplantation procedure. After 48 and 96 h posttransfection, samples were analyzed by RT-PCR for miR-146a expression (as described earlier).
Reverse transcription with miR-146a-specific primer, mmu-miR-146a (TaqMan MicroRNA Assays; Applied Biosystem), was performed to assess miR expression after antagomir transfection. To make cDNA for each TaqMan miR assay, we incubated 10 ng total RNA with 0.15 ml dNTPs (100 nM), 1.5 ml 103 reaction buffer, 0.19 ml RNase inhibitor, 1 ml reverse transcriptase, and 3 ml gene-specific primer in a 15-ml reaction. TaqMan MicroRNA Assay is a target-specific stem-loop, reverse-transcriptase primer highly specific only for mature miR and resulted in longer reverse transcription amplicon in range 50-150 bp according to manufactured specification. PCR fragments were resolved using MultiNA Microchip Electrophoresis System on gel for visualization of miR expression (Shimadzu Biotech, Milton Keynes, U.K.).
Luciferase reporter transfection and dual luciferase assay
In 39-untranslated region (UTR) assay, 5 3 10 4 HEK293 cells were transfected with 500 ng of the UTR reporter (pMir-Report) with inserted PGES-2 (420 bp), 20 pmol pre-miR-miR (miR-146a), and pre-miR (negative control; Ambion, Austin, TX), and 2 ml Lipofectamine 2000 (Invitrogen). Lysates were harvested 24 h after transfection, and reporter activity was measured with Dual Luciferase Reporter Assay (Promega).
Statistical analysis
All data are expressed as the mean 6 SD, and differences between groups were determined using the Student t test and Mann-Whitney U test; p values ,0.05 were considered significant.
Results miR expression profile in BMSCs in relation to their immunoregulatory potential for EAE
In a previous study, we demonstrated that mice transplanted i.v. with fBMSCs showed significantly lower clinical scores and faster recovery compared with control mice with EAE (34). However, transplantation of Lin 2 Sca-1 + BMSCs that had been induced to differentiate into cells expressing GFAP, NeuN, and O4 (nBMSCs) resulted in a diminished immunoregulatory effect on the course of EAE compared with the transplantation of fBMSCs. Therefore, in this study, we tested with unbiased approach both BMSC populations, fBMSCs and nBMSCs, for miR expression profiles to search for miR associated with their immunoregulatory potential. When clustering samples and genes, 30 of 757 miRs passed the filtering criteria on variation across samples (SD . 1.0) (35) (Table I) . Hence, these 30 miRs were used in the two-way hierarchical clustering analysis of genes. Analysis of log2(Hy3/ Hy5) ratios showed that the most upregulated miR during BMSCs cultured under neural differentiation conditions was miR-146a. The heat map diagram shows the result of the two-way hierarchical clustering of miRs and samples of nBMSCs differentiated in culture for 4 (nBMSC4d) or 7 (nBMSC7d) days versus fBMSCs (Fig. 1A) . Nineteen miRs were found to be upregulated and 11 downregulated during the neuronal differentiation process.
Among the differentially expressed miRs, miR-146a expression was increased most significantly in the nBMSCs that lack immunoregulatory function in EAE, compared with fBMSCs. To confirm the microarray data, we performed RT-PCR, which detected an increase of miR-146a expression up to 500-fold in nBMSCs compared with fBMSCs (Fig. 1B) .
MiR-146a inhibition reversed the loss of immunoregulatory function of nBMSCs
To confirm further the role of miR-146a in loss of immunoregulatory function of nBMSCs in EAE, we applied a selective miR146a antagonist (antagomir). Transfection of nBMSCs with miR146a antagomir resulted in stable decreased expression of up to 90% of miR-146a ( Fig. 2A, 2B) . Transplantation of these nBMSCs that had been transfected with the miR-146a antagomir resulted in amelioration of EAE comparable with that obtained with fBMSCs (Fig. 2C) . These results indicate that miR-146a represents a critical regulatory element in molecular mechanisms involved in the immunosuppressive activity of BMSCs in the EAE model. miR-146a inhibition restored the regulatory activity of differentiated nBMSCs on PLP-induced proliferation
In Fig. 3 , we show that the immunoregulatory activity of fBMSCs in EAE correlated with an inhibitory effect on PLP-induced T cell proliferation (p , 0.013), whereas nBMSCs, which were not efficient in EAE immunoregulation, did not show an effect on PLPinduced T cell proliferation. However, nBMSCs transfected with the miR-146a antagomir showed an inhibitory effect on proliferation of PLP-activated T cells (p , 0.0274) that was comparable with fBMSCs ( Fig. 3) . 
FIGURE 1. miR expression during BMSC neural differentiation. (A)
The heat-map diagram shows the result of the two-way hierarchical clustering of miRs and samples. Each row represents an miR, and each column represents a sample. The miR clustering tree is shown on the left, and the sample clustering tree appears at the top. The color scale shown at the bottom illustrates the relative expression level of an miR across all samples: red color represents an expression level above mean, and blue color represents expression lower than the mean. The clustering is performed on log2(Hy3/Hy5) ratios, which passed the filtering criteria on variation across samples; SD . 
MiR-146a is predicted to regulate the ptges2 gene
We next mapped miR-146a to its multiple predicted target mRNA transcripts in relation to their role in BMSC immunoregulatory function. We used several miR target software (www.mirbase.org [36] , www.targetscan.org, and www.microRNA.org) and consistently found that miR-146a was predicted to block PGE 2 synthase-2. It was of a particular interest that the ptges2 gene for PGE 2 synthase-2 was found to be high in the miR-146a predicted pool of genes, because PGE 2 has been shown to maintain the immunosuppressive function of BMSCs for allogeneic reactions (19) (20) (21) . In all databases, miR-146a was shown to target ptges2 with total context score 20.06 (37) and aggregate P CT , 0.1 (38) , which demonstrates high probability that ptges2 genes represent a conserved target for miR-146a. Fig. 4A indicates ptges2 sequence target sites of conserved miRs defined by miRSVR (support vector regression) score # 20.1 (39). miR-146 was the only miR identified earlier in the Exiqon miRCURY LNA array of miRs in nBMSCs that might target ptges2 transcript. We also did not find prediction of miR-146a for other genes related to PGE 2 synthesis: ptges, ptges3, ptgs1, or ptgs2. Thus, PGE 2 synthase-2 was selected for further testing in relation to miR-146a control of immunoregulatory function of BMSCs. To investigate whether ptges2 can be directly targeted by miR-146a, we engineered a luciferase reporter construct that contained a 420-bp fragment of the ptges2 gene. In HEK293 cells, the luciferase reporter was cotransfected with the miR-146a precursor (pre-miR-146a) or a nonspecific control pre-miR. The results showed that the pre-miR-146a significantly reduced luciferase activity, whereas the control premiR did not (Fig. 4B ).
Increased expression of miR-146a in nBMSCs correlates with inhibition of PGE synthase-2 and inhibition of PGE 2 release fBMSCs, which are capable of inhibiting EAE, showed high levels of PGE 2 production, whereas nBMSCs that lack EAE immunoregulatory function showed significantly lower secretion of PGE 2 (Fig. 5A) . PGE 2 is synthesized by three different PGE synthases: microsomal PGE synthase (mPGES)-1 and -2, and cytosolic PGE synthase (cPGES). Using specific Abs for all PGE 2 synthases, we detected expression of all three syntheses in fBMSCs, but in nBMSCs, expression of mPGES-2 coded by ptges2 was significantly decreased compared with fBMSCs (Fig. 5B) . We did not observe differences in expression levels of known miR-146a targets, IL-1R-associated kinase 1 and TNFR-associated factor 6, between fBMSCs and nBMSCs (Fig. 5C ).
Antagonism of miR-146a restores PGE synthase-2 expression and PGE 2 production in nBMSCs
To establish the role of miR-146a in regulation of PGE 2 production in BMSCs, we assessed the effect of the miR-146a antagomir on PGE 2 release. The results showed that nBMSCs transfected with miR-146a antagomir had decreased expression of miR-146a (∼90%) compared with control BMSCs cultured under the same conditions but not transfected with antagomiR-146a (Fig. 6A ). Most importantly, in nBMSCs transfected with miR-146a antagomir, we observed restoration of PGE 2 production (Fig. 6B) . Furthermore, PGE 2 release in nBMSCs transfected with miR-146a antagomir correlated with increased expression of mPGES-2 (Fig. 6C ). fBMSC coculture with PLP-reactive spleen cells induced strong inhibition of PLP-induced proliferation. nBMSCs showed a significantly milder inhibitory effect, but transfection with antagomiR-146a enhanced inhibition of PLP-reactive T cells (p , 0.003; Fig. 6D ).
To correlate further miR-146a expression levels with PGE 2 synthesis, we performed the reverse experiment and attempted to induce its expression in cBMSCs cultured in parallel with nBMSCs but without the neuronal differentiation conditions. cBMSCs produced ample amounts of PGE 2 and maintained immunoregulatory function similar to fBMSCs. cBMSCs transfected with pre-MirmiR-146a construct resulted in an increase in miR-146a expression by 200-fold (Fig. 7A) . Furthermore, cBMSCs transfected with pre-Mir-miR-146a showed a decrease in PGE 2 production (Fig. 7B ), which correlated with mPGES-2 synthesis inhibition (Fig. 7C) . Proliferation assay revealed loss of immunosuppressive potential of cBMSCs transfected with pre-miR-146a (Fig. 7D) . Thus, using both a loss-of-function approach with the miR-146a antagomir, as well as a gain of function with pre-Mir-miR-146a, we show that miR-146a controls PGE 2 synthesis in BMSCs.
Discussion
In a previous publication, we showed that freshly isolated Lin + BMSC was dependent on a nondifferentiated state and required secretion of PGE 2 (34) . In this study, we searched for molecular mechanisms that contributed to the immunoregulatory properties of freshly isolated nondifferentiated BMSCs. Based on recent progress in research identifying the role of miRs in the dynamic processes involved in cell differentiation and proliferation, we focused our studies on miRs (22) . miR profiling of fBMSC population, with high immunoregulatory activity, analyzed against BMSCs differentiated toward a neuronal phenotype (nBMSC), without immunoregulatory activity, showed a number of miRs that were differentially expressed. Nineteen miRs were upregulated and 11 downregulated as a result of the neuronal differentiation process. The most highly differentially expressed miR was miR146a, which in BMSCs cultured under neuronal differentiation conditions for 4-7 d was increased 500-fold. Because nBMSCs Western blot analysis using specific Abs for PGE 2 synthases showed expression of all three isoforms in BMSC, but following differentiation to nBMSC mPGES-2 levels decreased markedly. (C) We did not observe differences in expression levels of known miR-146a targets, IL-1R-associated kinase 1 and TNFRassociated factor 6, between fBMSCs and nBMSCs. In experiments, equal amounts of protein level per sample were loaded.
The Journal of Immunologyexpressing high miR-146a lost immunoregulatory function, we hypothesized that miR-146a might negatively regulate this property of BMSCs. We verified this assumption by experiments in which we selectively inhibited miR-146a in nBMSCs by transfection with a specific anti-miR-146a antagomir. nBMSCs transfected with the miR-146a antagomir showed a reduction in miR-146a expression and restoration of immunoregulatory activity in EAE.
The miR-146 family is composed of two members, miR-146a and miR-146b. To date, a role for miR-146 has been demonstrated in the development of multiple cancers (41) and in the negative regulation of inflammation induced via the innate immune response (42) . miR-146a expression has been shown to be induced in response to LPS, TNF-a, or IL-1b activation of TLR-2, -4, or -5 (43, 44) . Searching for miR-146a targets that might be of significance in the negative regulation of the immunoregulatory activity of BMSCs, we mapped miR-146a to its multiple predicted target mRNA transcripts using three independent miRs databases. Interestingly, miR-146a was found to interfere with the ptges2 gene that codes for PGE 2 synthase-2, in all three databases. PGE 2 in earlier studies was found to maintain the immunosuppressive activity of BMSCs toward allogeneic reactions. The immunosuppressive function of MSCs was noted in the absence of direct cell contact, indicating a role of soluble mediators like PGE 2 in dendritic cell maturation and inhibition of activated T lymphocyte proliferation (21); PGE 2 also contributed to the modulation of cytokine production by T cells (20) . MSC-mediated immunoregulation by PGE 2 was implicated in inhibition of TNF-a and IFN-g production by activating dendritic cells and T cells (19) . Of particular interest was that, in our previous study, we found that immunoregulation of EAE by BMSCs was dependent on PGE 2 secretion (34) . Freshly isolated BMSCs produced high amounts of PGE 2 and suppressed EAE development, whereas neuronal differentiated BMSCs lost PGE 2 secretion and were not able to immunoregulate EAE. Thus, PGE 2 synthases represent relevant targets for a role for miR-146a in the downregulation of the immunoregulatory activity of BMSCs. The functional dependence on the downregulation of ptges2 by miR-146a was directly shown in experiments using a luciferase reporter assay.
Biosynthesis of PGE 2 is mediated by three isoforms of PGE synthases (PGES): two mPGEs (mPGES-1 and mPGES-2) (44) and one cPGES (45) . mPGES-2 is an enzyme capable of coupling with both COX isoenzymes and is constitutively expressed in tissues (46) . The mPGES-2 transcript is abundantly distributed in cells in the brain, heart, skeletal muscle, kidney, and liver (44), whereas mPGES-1 transcript is primarily detected in organs related to the immune response (47) , suggesting that these two enzymes exhibit tissue specific functions. In experiments with nBMSCs transfected with an miR-146a antagomir, we detected increased expression of mPGES-2, but not mPGES-1 or cPGES. Thus, we hypothesized that miR-146a negatively controls BMSC immunoregulatory function by targeting ptges2 leading to diminished secretion of PGE 2 . To verify this hypothesis, we performed a series of loss-and gain-of-function experiments. For the former, we transfected nBMSCs with a selective miR-146a antagomir and demonstrated that an increase in PGE 2 secretion occurred in parallel to diminished miR-146a expression. In the gainof-function experiments, we induced miR-146a expression in BMSCs cultured in nondifferentiation conditions with pre-miR-146a construct. Parallel to the increase in miR-146a expression, we observed diminished PGE 2 secretion. Thus, we have demonstrated a negative correlation between miR-146a expression and PGE 2 synthesis in BMSCs, indicating that miR-146a, by targeting mPGES-2, negatively controls immunoregulatory activity of BMSCs.
In summary, we have shown for the first time, to our knowledge, that the molecular mechanism controlling the immunoregulatory activity of BMSCs depends on miR-146a. Increased expression of miR-146a after BMSC differentiation negatively controls the immunoregulatory properties of BMSCs by targeting the mPGES-2 gene. These results contribute to our understanding of the immunoregulatory properties of BMSCs and provide a target for engineering SCs with a high immunoregulatory profile that can potentially be used for the treatment of human autoimmune diseases.
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